A2780 (人卵巢癌细胞)(暂不出售）

参考文献

• MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB(2019/10/17)

  作者：Zhen Zhang, Luoyan Zhang, Bin Wang

  期刊：Cancer Letters

  DOI：10.1016/j.canlet.2019.10.021

  影响因子 ：9.756

  引用产品：CL-0005 CL-0013 CL-0079 CL-0178 CL-0215

• Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization(2017/05/08)

  作者：H Guo, Q Zhu, X Yu

  期刊：Oncogene

  DOI：10.1038/onc.2017.132

  影响因子 ：8.756

  引用产品：CL-0013 CL-0079 CL-0149 CL-0215

• Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1(2020/4/29)

  作者：Yun Zhang, Hao Ai, Xue Fan

  期刊：Biological Research

  DOI：10.1186/s40659-020-00286-3

  影响因子 ：7.6340

  引用产品：CL-0013 CL-0215

• Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer(2022/01/26)

  作者：Xuemei Liu, Zhiping Yin, Yanjun Wu

  期刊：Bioengineered

  DOI：10.1080/21655979.2022.2029109

  影响因子 ：6.8320

  引用产品：CL-0013 CL-0215 CL-0524 CM-0013 CM-0215 CM-0524 CM-0654

• CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3(2021/11/17)

  作者：Bo Li, Lu Zhang

  期刊：Journal of Ovarian Research

  DOI：10.1186/s13048-021-00875-0

  影响因子 ：5.5060

  引用产品：CL-0005 CL-0013 CL-0215 CP-H055

• Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis(2021/11/16)

  作者：Sifan Sun, Hailiang Fang

  期刊：Journal of Ovarian Research

  DOI：10.1186/s13048-021-00916-8

  影响因子 ：5.5060

  引用产品：CL-0005 CL-0013 CL-0215

• CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis(2021/08/31)

  作者：Wenwen Wang, Weiwei Zhang, Hongjun Guo

  期刊：Cell Cycle

  DOI：10.1080/15384101.2021.1965723

  影响因子 ：5.173

  引用产品：CL-0013 CL-0178 CL-0211 CL-0215

• Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9(2017/11/27)

  作者：Huidi Liu, Zheng Zeng, Siwen Wang

  期刊：Cancer Biology & Therapy

  DOI：10.1080/15384047.2017.1394542

  影响因子 ：4.875

  引用产品：CL-0013 CL-0079

• CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression(2018/12/18)

  作者：Ying Xu, Qing Zhang, Chunying Miao

  期刊：Cancer Medicine

  DOI：10.1002/cam4.1812

  影响因子 ：4.4520

  引用产品：CL-0013

• Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK(2021/3/13)

  作者：Jingfei Zheng, Xuehe Li, Weili Yang

  期刊：Journal Of Pharmacological Sciences

  DOI：10.1016/j.jphs.2021.02.001

  影响因子 ：4.3450

  引用产品：CL-0013

• Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3(2017/7/13)

  作者：Bingyu Zou, Hailian Wang, Yilong Liu

  期刊：Oncology Reports

  DOI：10.3892/or.2017.5814

  影响因子 ：4.1360

  引用产品：CL-0013

• LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer(2022/01/04)

  作者：Pengfei Zhao, Qingru Yun, Aodungerile Li

  期刊：Medical Oncology

  DOI：10.1007/s12032-021-01616-5

  影响因子 ：3.7380

  引用产品：CL-0013 CL-0215

• IQGAP3 promotes cancer proliferation and metastasis in high‑grade serous ovarian cancer(2020/5/21)

  作者：Samina Dongol, Qing Zhang, Chunping Qiu

  期刊：Oncology Letters

  DOI：10.3892/ol.2020.11664

  影响因子 ：3.1110

  引用产品：CL-0013

• miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells(2021/9/20)

  作者：Li Ma, Wei Zhang, Yaofeng Jin

  期刊：Experimental and Therapeutic Medicine

  DOI：10.3892/etm.2021.10754

  影响因子 ：2.7510

  引用产品：CL-0013 CL-0055 CL-0079 CL-0178

• 基于气相色谱 质谱的代谢组学技术研究紫杉醇诱导的卵巢癌 Ａ２７８０耐药株的生物标志物(2016/01)

  作者：崔广波, 刘晓昕

  期刊：南京工业大学学报

  DOI：10.3969/j.issn.1671-7627.2016.01.018

  影响因子 ：0.580

  引用产品：CL-0013

点击展开收起列表